75N94020D00019 - 75N94023F00001 - ovaprene phase i: protocol finalization, regulatory approval, start-up, and commencement of recruitment, screening and enrollment for the ovaprene vaginal device…
Ended Awarded Last action
- Contract number
- 75N94023F00001
- Awardee
-
The Regents Of The University Of Colorado UEI SPVKK1RC2MZ3
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $197,100
Award facts
- Contract value 100% obligated
- $197,100.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 18 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Aurora, CO 80045, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $116,520 | |
| Original award | $80,580 |
About this award
The National Institute of Child Health and Human Development (NICHD), a civilian federal agency, has awarded a $197,100.00 cost-plus-fixed-fee delivery order contract to the Regents of the University of Colorado, doing business as the University of Colorado Office of Contracts and Grants Division. This contract, awarded without a set-aside, is for the finalization of the protocol, regulatory approval, start-up, and commencement of recruitment, screening, and enrollment for the OVAPRENE vaginal device clinical trial. The University of Colorado is a U.S. state government entity and institution of higher learning that conducts fundamental research across STEM disciplines with potential defense, space, IT, healthcare, and environmental applications. The University has a history of successfully executing federal research and development contracts and grants, including work for NASA, the Department of Defense, and NOAA.
Description
75N94020D00019 - 75N94023F00001 - ovaprene phase i: protocol finalization, regulatory approval, start-up, and commencement of recruitment, screening and enrollment for the ovaprene vaginal device clinical trial.
Quick answers
Who was awarded contract 75N94023F00001?
75N94023F00001 was awarded to The Regents Of The University Of Colorado by National Institute of Child Health and Human Development (National Institutes of Health) on September 28, 2023.
How much is contract 75N94023F00001 worth?
The government has obligated $197,100 on 75N94023F00001.
Is contract 75N94023F00001 an order under another contract?
Yes. 75N94023F00001 is a delivery order under 75N94020D00019, an indefinite delivery contract.
Was contract 75N94023F00001 competed?
The extent of competition for 75N94023F00001 was full and open competition. The government received 18 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award